Trends in pricing and out-of-pocket spending on entecavir among commercially insured patients, 2014-2018 Journal Article uri icon

abstract

  • This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.

Link to Article

publication date

  • 2022